(Q40859444)

24 September 2017

1 reference

title

The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis (English)

1 reference

24 September 2017

0 references

0 references

1 reference

1

1 reference

24 September 2017

Lupia E

2

1 reference

24 September 2017

publication date

1 May 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

55

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

613-620

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855050-00001

24 September 2017

exact match

0 references

cites work

Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells.

1 reference

12 December 2020

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

1 reference

12 December 2020

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

12 December 2020

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

12 December 2020

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis

1 reference

12 December 2020

Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures

1 reference

12 December 2020

In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects

1 reference

12 December 2020

Role of cytokines in rheumatoid arthritis

1 reference

12 December 2020

Role of tumor necrosis factor-α and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis

1 reference

12 December 2020

Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

12 December 2020

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis

1 reference

12 December 2020

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

12 December 2020

Anticytokine therapy in rheumatoid arthritis

1 reference

12 December 2020

Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.

1 reference

12 December 2020

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis

1 reference

12 December 2020

Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor

1 reference

12 December 2020

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

1 reference

12 December 2020

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

1 reference

12 December 2020

Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.

1 reference

12 December 2020

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

12 December 2020

Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis

1 reference

12 December 2020

Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene.

1 reference

12 December 2020

An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein

1 reference

12 December 2020

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

12 December 2020

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

1 reference

12 December 2020

Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice

1 reference

12 December 2020

Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints

1 reference

12 December 2020

Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

12 December 2020

An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis

1 reference

12 December 2020

Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study

1 reference

12 December 2020

Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis

1 reference

12 December 2020

Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes

1 reference

12 December 2020

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

12 December 2020

Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice

1 reference

12 December 2020

Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein

1 reference

12 December 2020

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha

1 reference

12 December 2020

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

12 December 2020

10.2165/00003495-199855050-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1042635832

0 references

1 reference